380 related articles for article (PubMed ID: 20368440)
1. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis.
Wang L; Jin Q; Lee JE; Su IH; Ge K
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7317-22. PubMed ID: 20368440
[TBL] [Abstract][Full Text] [Related]
2. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis.
Wang L; Xu S; Lee JE; Baldridge A; Grullon S; Peng W; Ge K
EMBO J; 2013 Jan; 32(1):45-59. PubMed ID: 23178591
[TBL] [Abstract][Full Text] [Related]
3. MacroH2A1.1 cooperates with EZH2 to promote adipogenesis by regulating Wnt signaling.
Wan D; Liu C; Sun Y; Wang W; Huang K; Zheng L
J Mol Cell Biol; 2017 Aug; 9(4):325-337. PubMed ID: 28992292
[TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
5. Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.
Roy BC; Subramaniam D; Ahmed I; Jala VR; Hester CM; Greiner KA; Haribabu B; Anant S; Umar S
Oncogene; 2015 Aug; 34(34):4519-30. PubMed ID: 25486432
[TBL] [Abstract][Full Text] [Related]
6. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
[TBL] [Abstract][Full Text] [Related]
8. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.
Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ
Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
11. Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.
Jing H; Liao L; An Y; Su X; Liu S; Shuai Y; Zhang X; Jin Y
Mol Ther; 2016 Feb; 24(2):217-229. PubMed ID: 26307668
[TBL] [Abstract][Full Text] [Related]
12. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
McCabe MT; Ott HM; Ganji G; Korenchuk S; Thompson C; Van Aller GS; Liu Y; Graves AP; Della Pietra A; Diaz E; LaFrance LV; Mellinger M; Duquenne C; Tian X; Kruger RG; McHugh CF; Brandt M; Miller WH; Dhanak D; Verma SK; Tummino PJ; Creasy CL
Nature; 2012 Dec; 492(7427):108-12. PubMed ID: 23051747
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
Yap DB; Chu J; Berg T; Schapira M; Cheng SW; Moradian A; Morin RD; Mungall AJ; Meissner B; Boyle M; Marquez VE; Marra MA; Gascoyne RD; Humphries RK; Arrowsmith CH; Morin GB; Aparicio SA
Blood; 2011 Feb; 117(8):2451-9. PubMed ID: 21190999
[TBL] [Abstract][Full Text] [Related]
14. MAT2A promotes porcine adipogenesis by mediating H3K27me3 at Wnt10b locus and repressing Wnt/β-catenin signaling.
Zhao C; Wu H; Qimuge N; Pang W; Li X; Chu G; Yang G
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):132-142. PubMed ID: 29133280
[TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2.
Mandal M; Powers SE; Maienschein-Cline M; Bartom ET; Hamel KM; Kee BL; Dinner AR; Clark MR
Nat Immunol; 2011 Oct; 12(12):1212-20. PubMed ID: 22037603
[TBL] [Abstract][Full Text] [Related]
18. Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation.
Zemke M; Draganova K; Klug A; Schöler A; Zurkirchen L; Gay MH; Cheng P; Koseki H; Valenta T; Schübeler D; Basler K; Sommer L
BMC Biol; 2015 Nov; 13():103. PubMed ID: 26621269
[TBL] [Abstract][Full Text] [Related]
19. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
20. Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene.
Akpa MM; Iglesias DM; Chu LL; Cybulsky M; Bravi C; Goodyer PR
J Biol Chem; 2015 Jan; 290(4):2279-88. PubMed ID: 25331950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
